Emergent BioSolutions, Inc. (EBS)
6.23
0.00 (0.00%)
USD |
NYSE |
Oct 23, 16:00
6.24
+0.01
(+0.16%)
Pre-Market: 20:00
Emergent BioSolutions Price : 6.23 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 6.20 | 6.25 | 6.01 | 6.23 | 727361.0 |
| Oct 22, 2026 | 6.20 | 6.36 | 6.09 | 6.23 | 838559.0 |
| Oct 21, 2026 | 6.30 | 6.38 | 6.145 | 6.20 | 851823.0 |
| Oct 20, 2026 | 6.34 | 6.34 | 6.040 | 6.29 | 1.314M |
| Oct 19, 2026 | 6.40 | 6.579 | 6.35 | 6.36 | 817335.0 |
| Oct 16, 2026 | 6.64 | 6.73 | 6.150 | 6.38 | 2.238M |
| Oct 15, 2026 | 6.96 | 7.225 | 6.84 | 7.18 | 654821.0 |
| Oct 14, 2026 | 6.87 | 7.07 | 6.81 | 6.91 | 762216.0 |
| Oct 13, 2026 | 6.95 | 7.07 | 6.85 | 6.91 | 576155.0 |
| Oct 12, 2026 | 7.08 | 7.33 | 6.95 | 6.98 | 951242.0 |
| Oct 09, 2026 | 6.73 | 7.06 | 6.595 | 7.06 | 850964.0 |
| Oct 08, 2026 | 7.01 | 7.012 | 6.785 | 6.81 | 1.147M |
| Oct 07, 2026 | 7.05 | 7.35 | 6.84 | 7.07 | 1.235M |
| Oct 06, 2026 | 7.16 | 7.27 | 6.75 | 6.95 | 1.859M |
| Oct 05, 2026 | 6.53 | 7.650 | 6.45 | 7.24 | 2.348M |
| Oct 02, 2026 | 6.41 | 6.41 | 6.24 | 6.33 | 614591.0 |
| Oct 01, 2026 | 6.56 | 6.56 | 6.29 | 6.37 | 811231.0 |
| Sep 30, 2026 | 6.88 | 6.88 | 6.56 | 6.60 | 760581.0 |
| Sep 29, 2026 | 6.82 | 6.995 | 6.745 | 6.92 | 745108.0 |
| Sep 28, 2026 | 6.75 | 6.95 | 6.60 | 6.86 | 682897.0 |
| Sep 25, 2026 | 6.79 | 6.845 | 6.67 | 6.79 | 631362.0 |
| Sep 24, 2026 | 6.60 | 6.870 | 6.56 | 6.77 | 914341.0 |
| Sep 23, 2026 | 6.73 | 6.86 | 6.58 | 6.67 | 1.055M |
| Sep 22, 2026 | 6.61 | 6.89 | 6.54 | 6.76 | 1.144M |
| Sep 21, 2026 | 6.80 | 6.896 | 6.48 | 6.55 | 1.513M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exelixis, Inc. | 64.53 |
| Arcturus Therapeutics Holdings, Inc. | 9.84 |
| Capricor Therapeutics, Inc. | 5.93 |
| ADMA Biologics, Inc. | 10.68 |
| Akebia Therapeutics, Inc. | 0.5669 |
Price Related Metrics
| PS Ratio | 0.4388 |
| Price to Book Value | 0.9361 |
| Price to Free Cash Flow | 3.934 |
| Earnings Yield | -57.04% |
| Market Cap | 319.60M |
| Operating PE Ratio | 2.469 |